This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
250mg | $980 | Check With Us |
500mg | $1420 | Check With Us |
1g | $2130 | Check With Us |
Cat #: V4308 CAS #: 903576-44-3 Purity ≥ 98%
Description: Pitolisant HCl (formerly also known as BF2.649; BF2649; Ciproxidine; Wakix) is a nonimidazole-based inverse agonist of the recombinant human histamine H3 receptor approved in 2019 for the treatment of excessive daytime sleepiness in adults with narcolepsy.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 332.309 |
---|---|
Molecular Formula | C17H27Cl2NO |
CAS No. | 903576-44-3 |
Storage | -20℃ for 3 years in powder formrrrr |
-80℃ for 2 years in solvent | |
SMILES Code | ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1.[H]Cl |
Synonyms | FUB-649, BF-2649; B F2649; FUB649, BF2649; FUB 649; BF2.649; Pitolisant, Tiprolisant; Pitolisant HCl; Pitolisant hydrochloride |
Protocol | In Vitro | On the stimulation of guanosine 5′-O-(3-[35S]thio)triphosphate binding to this receptor, Pitolisant (BF2.649) behaves as a competitive antagonist with a Ki value of 0.16 nM and as an inverse agonist with an EC50 value of 1.5 nM and an intrinsic activity ~50% higher than that of ciproxifan. Pitolisant displaces [125I]iodoproxyfan binding from mouse brain cortical membranes with an IC50 value of 26.4±4.5 nM. Taking into account the Kd value of the radioligand (161±9 pM), the deduced Ki value for Pitolisant is 14±1 nM. Pitolisant displaces [125I]iodoproxyfan binding from membranes of rat glioma C6 cells stably expressing the human H3 receptor with an IC50 value of 4.2±0.2 nM. Taking into account the Kd value of the radioligand (50±4 pM), the deduced Ki value for Pitolisant is 2.7±0.5 nM. Pitolisant progressively reverses this response with a Hill coefficient close to unity and an IC50 value of 330±68 nM, leading to a Ki value of 17±4 nM. Pitolisant elicits a dose-dependent decrease of the basal-specific [35S]GTPγS binding to membranes with a maximal effect corresponding to 75±1% of the basal-specific binding and an EC50 value of 1.5±0.1 nM |
---|
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 3.0092 mL | 15.0462 mL | 30.0925 mL | 60.1849 mL |
5mM | 0.6018 mL | 3.0092 mL | 6.0185 mL | 12.0370 mL |
10mM | 0.3009 mL | 1.5046 mL | 3.0092 mL | 6.0185 mL |
20mM | 0.1505 mL | 0.7523 mL | 1.5046 mL | 3.0092 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.